Abstract
The discovery of opioid receptor expression on immune cells has originated a large research activity on the possible modulation by opioid drugs of immune system responses. In this chapter we describe an easy methodology useful to obtain information about the potential immunomodulatory activity of opioid drugs. An in vivo treatment schedule is used, and macrophages are studied for their ability to release different cytokines.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Franchi S, Moschetti G, Amodeo G et al (2019) Do all opioid drugs share the same immunomodulatory properties? A review from animal and human studies. Front Immunol 12(10):2914. https://doi.org/10.3389/fimmu.2019.02914. eCollection 2019
Sacerdote P, Franchi S, Moretti S et al (2012) Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain. J Neuroimmune Pharmacol 8:202–211
Vallejo R, de Leon-Casasola O, Benyamin R (2004) Opioid therapy and immunosuppression: a review. Am J Ther 11:354–365
Martucci C, Franchi S, Lattuada D et al (2007) Differential involvement of RelB in morphine-induced modulation of chemotaxis, NO, and cytokine production in murine macrophages and lymphocytes. J Leukoc Biol 81:344–354
Franchi S, Moretti S, Castelli M et al (2012) Sacerdote P mu opioid receptor activation modulates toll like receptor 4 in murine macrophage. Brain Behav Immun 26:480–488
Sacerdote P, Martucci C, Vaccani A et al (2005) The non-psychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. J Neuroimmunol 159:97–105
Gaveriaux-Ruff C, Matthes HW, Peluso J et al (1998) Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene. Proc Natl Acad Sci U S A 95:6326–6330
Bidlack JM, Khimich M, Parkhill AL et al (2006) Opioid receptors and signaling on cells from the immune system. J Neuroimmune Pharmacol 1:260–269
Roy S, Barke RA, Loh HH (1998) Mu-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res 61:190–194
Wang J, Charboneau R, Balasubramanian S et al (2002) The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor. J Leukoc Biol 71:782–790
Fecho K, Maslonek KA, Dykstra LA et al (1996) Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther 277:633–645
Limiroli E, Gaspani L, Panerai AE et al (2002) Differential morphine tolerance development in the modulation of macrophage cytokine production in mice. J Leukoc Biol 72:43–48
Martucci C, Franchi S, Giannini E et al (2006) Bv8, the amphibian homologue of the mammalian prokineticins, induces a pro-inflammatory phenotype of mouse macrophages. Br J Pharmacol 147:225–234
Einsenstein TK (2019) The role of opioid receptors in immune system function. Front Immunol 10:2904. https://doi.org/10.3389/fimmu.2010.02904. eCollection 2019
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Franchi, S., Castelli, M., Moretti, S., Panerai, A., Sacerdote, P. (2021). Evaluation of Murine Macrophage Cytokine Production After In Vivo Morphine Treatment. In: Spampinato, S.M. (eds) Opioid Receptors. Methods in Molecular Biology, vol 2201. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0884-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0884-5_18
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0883-8
Online ISBN: 978-1-0716-0884-5
eBook Packages: Springer Protocols